Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient Cells.
Cancers
Bougen-Zhukov, Nicola N; Nouri, Yasmin Y; Godwin, Tanis T; Taylor, Megan M; Hakkaart, Christopher C; Single, Andrew A; Brew, Tom T; Permina, Elizabeth E; Chen, Augustine A; Black, Michael A MA; Guilford, Parry P
AKT1 (E17K) mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection.
Bmc Cancer
Rudolph, Marion M; Anzeneder, Tobias T; Schulz, Anke A; Beckmann, Georg G; Byrne, Annette T AT; Jeffers, Michael M; Pena, Carol C; Politz, Oliver O; Köchert, Karl K; Vonk, Richardus R; Reischl, Joachim J